Noninvasive Evaluation of Liver Function in Morbidly Obese Patients.
Patrick H AlizaiIsabella LurjeAndreas KrohSophia SchmitzTom LueddeJulia AndruszkowUlf P NeumannFlorian UlmerPublished in: Gastroenterology research and practice (2019)
Obese patients show a diminished liver function capacity, especially those suffering from type 2 diabetes. The liver function capacity correlates with histological and clinical scoring systems. The LiMAx® test may be a valuable tool for noninvasive screening for NASH in obese patients.